Cleared Traditional

K880874 - IMMUNOADSORBED FACTOR VII DEFICIENT PLA...

K880874 is the FDA 510(k) clearance for IMMUNOADSORBED FACTOR VII DEFICIENT PLA... by Baxter Healthcare Corp. It is a Class 2 Hematology device (product code GJT) cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K880874 · Baxter Healthcare Corp · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1988
Decision
16d
Days
Class 2
Risk

K880874 is an FDA 510(k) clearance for the IMMUNOADSORBED FACTOR VII DEFICIENT PLASMA HUMAN. Classified as Plasma, Coagulation Factor Deficient (product code GJT), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Miami, US). The FDA issued a Cleared decision on March 17, 1988 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

Submission Details

510(k) Number K880874 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 1988
Decision Date March 17, 1988
Days to Decision 16 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 113d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GJT Plasma, Coagulation Factor Deficient
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GJT Plasma, Coagulation Factor Deficient

All 60
Devices cleared under the same product code (GJT) and FDA review panel - the closest regulatory comparables to K880874.
ORTHO FACTOR X DEFICIENT PLASMA
K883690 · Ortho Diagnostic Systems, Inc. · Nov 1988
ORTHO FACTOR XI DEFICIENT PLASMA
K883691 · Ortho Diagnostic Systems, Inc. · Nov 1988
ORTHO FACTOR VII DEFICIENT PLASMA
K883692 · Ortho Diagnostic Systems, Inc. · Nov 1988
FACTOR VIII REFERENCE PLASMA
K880292 · Helena Laboratories · Feb 1988